CLEAN : Health workers receive first jabs of controversial Covaxin in India

The transcript discusses the efficacy of vaccines, personal vaccination choices, and the challenges faced due to limited availability of certain vaccines like COVID Shield and Pfizer. It highlights the importance of phase three clinical trial data and the expectations from ongoing trials involving thousands of volunteers. The speaker expresses hope for positive results and effective vaccine applications in the future.

What factors did the speaker consider when discussing the choice of vaccine?

What did the speaker hope for regarding the results of the phase three trials?